Status:
COMPLETED
Hydrodissection as a Treatment for Carpal Tunnel Syndrome
Lead Sponsor:
Mayo Clinic
Conditions:
Carpal Tunnel Syndrome
Eligibility:
All Genders
21-80 years
Phase:
NA
Brief Summary
This is a pilot study designed to acquire data on the added value of hydrodissection when using a corticosteroid injection as a treatment for patients with carpal tunnel syndrome. Hydrodissection is p...
Eligibility Criteria
Inclusion
- Clinical CTS diagnosis with indication for steroid injection as determined by attending physician (if both hands are involved, only the side with the most severe CTS as indicated by electromyography (EMG) will be included) AND
- adult men and women between age 21 and 80 AND
- no more than moderate severity as indicated by EMG AND
- symptoms of numbness or tingling for at least 4 weeks in the median nerve distribution area AND
- classic or probable carpal tunnel syndrome on Katz-Stirrat hand diagram AND
- ability to complete English-language questionnaires and clinical evaluations AND
- is reachable by phone for the follow up contact
Exclusion
- Exclusion criteria are largely based on the premises of only including patients with idiopathic carpal tunnel syndrome without expected interferences of the acquisition of the ultrasound images or corticosteroid treatment.
- Previous Carpal Tunnel Release (CTR) or other volar wrist surgery on the study hand OR known tumor/mass OR deformity of the study hand/wrist OR
- previous history of steroid injection into carpal tunnel OR
- currently taking a steroid medication either regularly or on an as needed basis OR
- any of the following clinical diagnoses or conditions: Cervical radiculopathy; rheumatoid or other inflammatory arthritis, including gout; osteoarthritis in the wrist; renal failure; sarcoidosis; peripheral nerve disease; diabetes, thyroid disease or other metabolic disorder; pregnancy; amyloidosis; or major trauma (fractures or complete ligamentous tears) to the ipsilateral arm OR
- prisoners, institutionalized individuals, or others who may be considered vulnerable populations, such as individuals with dementia
Key Trial Info
Start Date :
March 8 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03427983
Start Date
March 8 2018
End Date
July 31 2019
Last Update
August 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905